Overcoming drug resistance for tuberculosis

Future Microbiol. 2015;10(11):1735-41. doi: 10.2217/fmb.15.76. Epub 2015 Oct 30.

Abstract

Despite enormous progress, tuberculosis (TB) is still a major global health problem. Poor patients' adherence to the current treatment leads to the emergence of multidrug resistant (MDR) and extensively drug resistant (XDR) strains. While increased numbers of MDR-TB cases can be ascribed to difficulties in treating TB-HIV coinfected patients, many studies demonstrated that the emergence of drug-resistant TB is clearly linked to misdiagnosis and mismanagement of drug-susceptible TB. Therefore, rapid detection and proper treatment are needed globally to both cure TB patients and prevent wide spreading of the disease. This paper provides a survey of the major strategies that have been explored for overcoming drug resistance in TB.

Keywords: MDR-TB; XDR-TB; drug resistance; tuberculosis.

Publication types

  • Review

MeSH terms

  • Antitubercular Agents / pharmacology*
  • Antitubercular Agents / therapeutic use*
  • Diagnostic Tests, Routine / methods
  • Diagnostic Tests, Routine / standards
  • Drug Resistance, Bacterial*
  • Drug Therapy / methods
  • Drug Therapy / standards
  • Humans
  • Medication Adherence
  • Mycobacterium / drug effects*
  • Tuberculosis / diagnosis
  • Tuberculosis / drug therapy*
  • Tuberculosis / microbiology*

Substances

  • Antitubercular Agents